arginyl-glycyl-aspartic acid has been researched along with Cancer of Esophagus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Y; Cui, C; Fan, Z; Pan, Z; Sun, L; Wang, DH; Zhang, M | 1 |
| Bergman, JJ; Bosma, PJ; Buskens, CJ; Marsman, WA; Offerhaus, GJ; Tytgat, GN; van Lanschot, JJ; Wesseling, JG | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Cancer of Esophagus
| Article | Year |
|---|---|
Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Drug Compounding; Drug Delivery Systems; Drug Monitoring; Epirubicin; Esophageal Neoplasms; Fluorescence; Humans; Injections, Intraperitoneal; Integrin alphaVbeta3; Male; Mice; Mice, Nude; Molecular Imaging; Nanoparticles; Oligopeptides; Peptides, Cyclic; Spectroscopy, Near-Infrared; Xenograft Model Antitumor Assays | 2018 |
Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo.
Topics: Adenoviridae; Barrett Esophagus; Carcinoma; Cell Line, Tumor; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Esophageal Neoplasms; Flow Cytometry; Genetic Therapy; Genetic Vectors; Humans; Immunochemistry; Oligopeptides; Receptors, Virus; Transduction, Genetic | 2004 |